BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2018
View Archived Issues
Rheos Medicines launches with series A financing
Read More
Multivalent filovirus vaccines demonstrate immunogenicity and protection in nonhuman primates
Read More
European Commission approves Alofisel
Read More
EMA committee backs approval of Sandoz's biosimilar infliximab
Read More
New macrocyclic alpha-hydroxyphenylacetamide Mcl-1 inhibitor with in vivo efficacy against myeloma
Read More
Juluca receives positive opinion from EMA's CHMP
Read More
Cellivery investigates leptin-targeting antiobesity therapy
Read More
EMA committee issues negative opinion on Portola's betrixaban
Read More
First patient enrolled in phase III AEGIS-II study of CSL-112
Read More
VISTA protein identified as a biomarker and target in malignant pleural mesothelioma
Read More
Prevymis tablets and i.v. infusion approved in Japan
Read More
IMpower150 study of Tecentriq in NSCLC meets coprimary endpoint of overall survival
Read More
Phase IIb study of RPL-554 in COPD meets primary endpoint
Read More
Bayer Yakuhin receives Japanese approval of Sivextro
Read More
hVIVO reports initial results from phase IIb influenza challenge study of FLU-v
Read More
EMA recommends including new indication in Repatha label
Read More
European Commission grants orphan drug designation to ARGX-113 for myasthenia gravis
Read More
First-in-human data for KM-819 presented at ASCPT
Read More
Japanese authorities expand indication for Tafinlar and Mekinist combination therapy
Read More
IFM Therapeutics describes novel stimulator of interferon genes protein agonists
Read More
Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical Group patent CDK inhibitors
Read More
Amgen, Allergan receive positive opinion in E.U. for ABP-980
Read More
Novel thrombopoietin receptor agonists synthesized at Sichuan Kelun-Biotech Biopharmaceutical
Read More
Gachon University identifies novel AChE/NO production inhibitors
Read More
New indication, new formulation of Signifor LAR approved in Japan
Read More
Bristol-Myers Squibb discovers new Toll-like receptor 7, 8 and 9 antagonists
Read More
Lenvima approved in Japan for unresectable HCC
Read More
Peloton initiates phase II study of PT-2977 for VHL-associated renal cell carcinoma
Read More
Genentech develops anti-inflammatory nuclear receptor ROR-gamma inverse agonists
Read More
CHMP supports conditional marketing authorization for Clovis Oncology's Rubraca
Read More